Eco Animal Health Group's EBIT per Share for the
six
months ended in Sep. 2025 was €0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was €0.11.
During the past 12 months, the average EBIT per Share Growth Rate of Eco Animal Health Group was 171.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -2.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -18.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -9.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Eco Animal Health Group's EBIT per Share or its related term are showing as below:
STU:LWA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -76.1 Med: 12 Max: 270.8
Current: -2.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Eco Animal Health Group was 270.80% per year. The lowest was -76.10% per year. And the median was 12.00% per year.
STU:LWA's 3-Year EBIT Growth Rate is ranked worse than 65.06% of 810
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs STU:LWA: -2.60
Eco Animal Health Group (STU:LWA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Eco Animal Health Group EBIT per Share Related Terms
Eco Animal Health Group EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eco Animal Health Group (STU:LWA) has a EBIT per Share of €0.11 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Eco Animal Health Group and its competitors. According to the industry distribution chart, Eco Animal Health Group ranks #527 out of 810 companies in the Drug Manufacturers industry, placing it in the top 65.1%.
Is Eco Animal Health Group's EBIT per Share too high?
Eco Animal Health Group's current EBIT per Share is €0.11. Based on the distribution chart, Eco Animal Health Group ranks #527 out of 810 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Eco Animal Health Group has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eco Animal Health Group ranks #527 out of 810 companies for EBIT per Share. This places Eco Animal Health Group in the lower half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Eco Animal Health Group and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current EBIT per Share is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Based on GuruFocus' analysis, Eco Animal Health Group (STU:LWA) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.14, compared to a current price of €0.98 — trading 14% below its estimated fair value. The current EBIT per Share is €0.11. Eco Animal Health Group's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Eco Animal Health Group (STU:LWA), the current EBIT per Share is €0.11 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eco Animal Health Group (STU:LWA) Overvalued in 2026?
Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued.
The current stock price of €0.98 is trading 14% below its estimated GF Value™ of €1.14.
GuruFocus considers Eco Animal Health Group to be Modestly Undervalued.
Key valuation signals for STU:LWA:
EBIT per Share: €0.11
GF Value™: €1.14 vs. price of €0.98 (14% below fair value)
No single metric tells the full story. See the STU:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
67GF Score
Get the complete analysis for STU:LWA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LWA has been successfully added to your 
